Single-Agent Chemotherapy Still Preferred To Biological Therapies For Treatment Of Metastatic Melanoma

There is no evidence to suggest that clinicians should choose a combination of biological therapies---treatments that boost or restore the ability of the body's defense system to fight disease---and chemotherapy over the commonly used single-agent chemotherapy regimen for patients with metastatic melanoma, according to the results of a meta-analysis published in the Journal of Clinical Oncology. More at...